Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£ ÀüÀ̸¦ µ¿¹ÝÇÑ ´ëÀå¾Ï¿¡¼­ÀÇ VEGF-A, VEGFR-1, VEGFR-2 ¹ßÇö ¾ç»ó°ú ¹Ì¼¼Ç÷°ü ¹ÐµµÀÇ ºñ±³ Differences in Expression of VEGF-A, VEGFR-1, VEGFR-2 and Microvessel Density in Colorectal Cancer with Liver Metastasis

´ëÇѺ´¸®ÇÐȸÁö 2010³â 44±Ç 6È£ p.571 ~ 580
Á¤ÀºÈñ, ±è¿µ, ¹Îº´¿ì, ÀÌ°æÈ­, ±èÇö¼ö, ÀÌÁ¦Çõ,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤ÀºÈñ ( Jeong Eun-Hui ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

±è¿µ ( Kim Young ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Îº´¿ì ( Min Byeong-Woo ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌ°æÈ­ ( Lee Kyung-Hwa ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èÇö¼ö ( Kim Hyun-Soo ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç ¼ÒÈ­±âºÐ°ú
ÀÌÁ¦Çõ ( Lee Jae-Hyuk ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background : Colorectal cancer (CRC) is one of the most common malignant neoplasms and is a leading cause of mortality worldwide. Metastasis to the liver is a frequent event in patients with CRC. An essential step in the metastatic cascade is angiogenesis.

Methods : This study included 45 patients who underwent a partial colectomy with hepatic resection for CRC with hepatic metastases. Immunohistochemistry was performed using vascular endothelial growth factor (VEGF)-A, VEGF receptor (VEGFR)-1, VEGFR-2, and CD34 antibodies to examine the relationship between CRC with liver metastases and angiogenesis.

Results : CRC showed significantly stronger expression of VEGF-A, VEGFR-1, and VEGFR-2 than liver metastases (p < 0.05). Microvessel density was also higher in CRC than in liver metastases (p < 0.05).

Conclusions : Compared with previous studies, we found a higher expression of VEGF-A, VEGFR-1, VEGFR-2, and microvessel density in CRC than in liver metastases, which could be ascribed to a difference in vessel distribution and blood supply in each organ. Given its profuse blood supply and distinct cell populations, the liver might provide a rich milieu for tumor cell growth with less expression of angiogenesis-inducing agents.

Å°¿öµå

Thymus gland; Neoplasms; Immunohistochemistry; World Health Organization; Histological classification

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS